Veterinary Medicines

BIMACURE 500 MG INTRAUTERINE SUSPENSION FOR CATTLE

Authorised
  • Cefapirin benzathine
Download as PDF

Product identification

Medicine name:
Bimacure 500 mg Suspension zur intrauterinen Anwendung für Rinder
BIMACURE 500 MG INTRAUTERINE SUSPENSION FOR CATTLE
Active substance:
  • Cefapirin benzathine
Target species:
  • Cattle
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Cefapirin benzathine
    640.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intrauterine suspension
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France S.A.S.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402731.00.00
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0419/001
Concerned member states:
  • Austria
  • Estonia
  • Germany
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Spain

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 29/09/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."